Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for HHT Epistaxis
NCT00375622Phase 2Completed
- Sponsor
- Rabin Medical Center
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in hereditary hemorrhagic telangiectasia (HHT), sponsored by Rabin Medical Center. Started Feb 2005; status: completed.
02
Drugs
tamoxifen
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT00375622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375622.